3D Systems Management

Management Kriterienprüfungen 1/4

3D Systems CEO ist Jeff Graves , ernannt in May 2020, hat eine Amtszeit von 4.5 Jahren. Die jährliche Gesamtvergütung beträgt $6.54M , bestehend aus 13% Gehalt und 87% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.77% der Aktien des Unternehmens, im Wert von MX$73.13M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.9 Jahre bzw. 7.4 Jahre.

Wichtige Informationen

Jeff Graves

Geschäftsführender

US$6.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	13.0%
Amtszeit als Geschäftsführer	4.5yrs
Eigentum des Geschäftsführers	0.8%
Durchschnittliche Amtszeit des Managements	1.9yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	7.4yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Jeff Graves im Vergleich zu den Einnahmen von 3D Systems verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	-US$348m
Mar 31 2024	n/a	n/a	-US$350m
Dec 31 2023	US$7m	US$850k	-US$363m
Sep 30 2023	n/a	n/a	-US$96m
Jun 30 2023	n/a	n/a	-US$122m
Mar 31 2023	n/a	n/a	-US$126m
Dec 31 2022	US$6m	US$850k	-US$123m
Sep 30 2022	n/a	n/a	-US$104m
Jun 30 2022	n/a	n/a	US$227m
Mar 31 2022	n/a	n/a	US$250m
Dec 31 2021	US$9m	US$837k	US$322m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	-US$57m
Mar 31 2021	n/a	n/a	-US$85m
Dec 31 2020	US$6m	US$489k	-US$150m

Vergütung im Vergleich zum Markt: JeffDie Gesamtvergütung ($USD6.54M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt MX ($USD243.27K).

Entschädigung vs. Einkommen: JeffDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Jeff Graves (63 yo)

4.5yrs

Amtszeit

US$6,535,630

Vergütung

Dr. Jeffrey Alan Graves, also known as Jeff, is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is P...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jeffrey Graves	President	4.5yrs	US$6.54m	0.77% MX$ 73.1m
Reji Puthenveetil	Executive Vice President of Industrial Solutions	4.3yrs	US$2.31m	0.27% MX$ 26.0m
Jeffrey Creech	Executive VP	less than a year	US$845.99k	0.13% MX$ 12.6m
Phyllis Nordstrom	Executive VP	3.3yrs	US$2.10m	0.12% MX$ 11.7m
Charles Hull	Co-Founder	no data	keine Daten	0.43% MX$ 40.5m
Joseph Zuiker	Executive Vice President of Engineering & Operations	1.9yrs	keine Daten	0.11% MX$ 10.8m
Michael McCloskey	Treasurer & VP of Investor Relations	no data	keine Daten	keine Daten
Andrew Wright	Senior VP of General Counsel & Corporate Secretary	less than a year	keine Daten	keine Daten
Harriss Currie	President - Regenerative Medicine	less than a year	keine Daten	0.096% MX$ 9.1m

1.9yrs

Durchschnittliche Betriebszugehörigkeit

60.5yo

Durchschnittliches Alter

Erfahrenes Management: DDD *Das Führungsteam des Unternehmens gilt nicht als erfahren ( 1.9 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jeffrey Graves	President	4.8yrs	US$6.54m	0.77% MX$ 73.1m
Charles Hull	Co-Founder	no data	keine Daten	0.43% MX$ 40.5m
Jim Kever	Independent Director	28.8yrs	US$220.00k	0.36% MX$ 34.4m
Thomas Erickson	Independent Director	9yrs	US$228.76k	0.24% MX$ 22.7m
Kevin Moore	Independent Director	25.1yrs	US$245.00k	0.18% MX$ 17.2m
Charles McClure	Independent Chairman of the Board	7.7yrs	US$400.00k	0.11% MX$ 10.8m
William Curran	Independent Director	16.8yrs	US$255.00k	0.11% MX$ 10.1m
John Tracy	Independent Director	7.4yrs	US$240.00k	0.11% MX$ 10.7m
Stephen Klasko	Chair of Medical Advisory Board	2.5yrs	keine Daten	keine Daten
Malissia Clinton	Independent Director	5.7yrs	US$240.00k	0.094% MX$ 8.9m
Vasant Padmanabhan	Independent Director	3.9yrs	US$216.24k	0.088% MX$ 8.4m
Claudia Drayton	Independent Director	2.9yrs	US$218.11k	0.075% MX$ 7.1m

7.4yrs

Durchschnittliche Betriebszugehörigkeit

70yo

Durchschnittliches Alter

Erfahrener Vorstand: DDD *Die Vorstandsmitglieder gelten als erfahren (7.4 Jahre durchschnittliche Amtszeit).

3D Systems Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought Mex$4.5m worth of stock

Independent Director recently bought Mex$3.9m worth of stock

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

Recent updates

3D Systems Corporation to Report Q3, 2024 Results on Nov 25, 2024

3D Systems Empowers Innovation, Transforms Industries with New Products At Formnext 2024

3D Systems Corporation(NYSE:DDD) dropped from S&P 600 Industrials (Sector)

3D Systems Expands High Precision Investment Casting Portfolio with QuickCast Air

3D Systems Corporation Updates Earnings Guidance for the Full-Year 2024

3D Systems Corporation to Report Q1, 2024 Results on Aug 19, 2024

3D Systems Corporation to Report First Half, 2024 Results on Aug 26, 2024

3D Systems Corporation announced delayed 10-Q filing

3D Systems Introduces Ext 800 Titan Pellet - Expanding Accessibility of Industrial Extrusion Platform

3D Systems Corporation announced delayed 10-Q filing

3D Systems Announces FDA Clearance for 3D-Printed Pek Cranial Implants

3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing

3D Systems Corporation announced delayed annual 10-K filing

3D Systems Corporation Reports Unaudited Consolidated Impairment Charges Results for the Fourth Quarter Ended December 31, 2023

3D Systems Introduces First Multi-Material, One-Piece Jetted Denture Solution

3D Systems Corporation to Report Q4, 2023 Results on Feb 27, 2024

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought Mex$4.5m worth of stock

Independent Director recently bought Mex$3.9m worth of stock

Third quarter 2023 earnings released: US$0.09 loss per share (vs US$0.30 loss in 3Q 2022)

3D Systems Corporation to Report Q3, 2023 Results on Nov 08, 2023

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation Announces CFO Changes

the Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of 3D Systems Corporation Publicly-Traded Common Stock

Second quarter 2023 earnings released: US$0.22 loss per share (vs US$0.26 loss in 2Q 2022)

3D Systems Corporation Revises Earnings Guidance for the Full Year 2023

3D Systems Corporation to Report Q2, 2023 Results on Aug 09, 2023

3D Systems Introduces New Materials Engineered to Expand Capabilities of SLA and Figure 4 Platforms

New minor risk - Shareholder dilution

Insider recently sold Mex$2.6m worth of stock

3D Systems Corporation (NYSE:DDD) submitted a non-binding proposal to acquire Stratasys Ltd. (NasdaqGS:SSYS) for $1.3 billion.

Independent Director recently sold Mex$1.3m worth of stock

3D Systems Corporation Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.23 loss per share (vs US$0.21 loss in 1Q 2022)

Full year 2022 earnings released: US$0.96 loss per share (vs US$2.62 profit in FY 2021)

3D Systems Introduces ProJet MJP 2500W Plus — New 3D Printing Solution for Jewelry Manufacturing Dramatically Improves Productivity

3D Systems Appoints Dr. Rebekah Gee as Member of Its Medical Advisory Board, Effective March 1, 2023

3D Systems Corporation to Report Q4, 2022 Results on Feb 28, 2023

rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual

High number of new directors

3D Systems Appoints Bert Bruce to its Medical Advisory Board

High number of new directors

Executive VP recently sold Mex$1.4m worth of stock

3D Systems Announces Management Appointments

High number of new directors

High number of new directors

3D Systems Corporation Revises Earnings Guidance for the Fiscal Year 2022

3D Systems Corporation to Report Q3, 2022 Results on Nov 08, 2022

High number of new directors

3D Systems Corporation Announces Appointment of Andrew Johnson as Chief Corporate Development Officer

Executive VP recently sold Mex$1.4m worth of stock

3D Systems Corporation Appoints Taci Pereira as Systemic Bio’s Chief Executive Officer

3D Systems Announces First to Market Cuni (Cuni30) Alloy for Laser Powder Bed Fusion

3D Systems Corporation Announces Executive Changes

3D Systems Announces Board Changes

Second quarter 2022 earnings released: US$0.26 loss per share (vs US$0.079 loss in 2Q 2021)

3D Systems Corporation (NYSE:DDD) agreed to acquire dp polar GmbH from Hans Mathea.

3D Systems Announces Appointment of the Honorable Alex M. Azar II to Its Medical Advisory Board

3D Systems Appoints Michael Turner as Executive Vice President, Effective August 29, 2022

High number of new directors

3D Systems Corporation to Report Q2, 2022 Results on Aug 08, 2022

High number of new directors

Co-Founder recently sold Mex$5.7m worth of stock

3D Systems Corporation Announces Appointment of David J. Shulkin to Medical Advisory Board

President recently bought Mex$2.1m worth of stock

3D Systems Announces Establishment of Medical Advisory Board & Appointment of Stephen K. Klasko as Chair

First quarter 2022 earnings released: US$0.21 loss per share (vs US$0.37 profit in 1Q 2021)